Organogenesis Holdings (ORGO) Debt to Equity: 2017-2024
Historic Debt to Equity for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2024 value amounting to $0.22.
- Organogenesis Holdings' Debt to Equity fell 8.67% to $0.22 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.92, marking a year-over-year decrease of 7.96%. This contributed to the annual value of $0.24 for FY2023, which is 10.78% down from last year.
- Per Organogenesis Holdings' latest filing, its Debt to Equity stood at $0.22 for Q3 2024, which was down 7.45% from $0.24 recorded in Q2 2024.
- In the past 5 years, Organogenesis Holdings' Debt to Equity registered a high of $1.67 during Q2 2020, and its lowest value of $0.22 during Q3 2024.
- Moreover, its 3-year median value for Debt to Equity was $0.25 (2023), whereas its average is $0.26.
- As far as peak fluctuations go, Organogenesis Holdings' Debt to Equity increased by 7.85% in 2020, and later crashed by 79.96% in 2021.
- Quarterly analysis of 5 years shows Organogenesis Holdings' Debt to Equity stood at $0.54 in 2020, then plummeted by 43.72% to $0.30 in 2021, then declined by 12.45% to $0.27 in 2022, then fell by 10.78% to $0.24 in 2023, then fell by 8.67% to $0.22 in 2024.
- Its Debt to Equity was $0.22 in Q3 2024, compared to $0.24 in Q2 2024 and $0.23 in Q1 2024.